A surprising hyperpigmentation of the gums and tongue

Gut

Volumn 57, Issue 12, 2008, Pages

  Dell'Isola, S ^a   Ialungo, A M ^a   Starnini, G ^a   Roselli, P ^a   Ghittoni, G ^b   Caturelli, E ^a  

^a BELCOLLE HOSPITAL   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; RIBAVIRIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; GUM HYPERPIGMENTATION; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HYPERPIGMENTATION; PRIORITY JOURNAL; SIDE EFFECT; TONGUE HYPERPIGMENTATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIVIRAL AGENTS; FEMALE; GINGIVAL DISEASES; HEPATITIS C, CHRONIC; HUMANS; HYPERPIGMENTATION; INTERFERON ALFA-2B; RIBAVIRIN; TONGUE DISEASES;

EID: 56549100133     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.160184     Document Type: Article

References (7)

1. Sookian S, Neglia V, Castaño G, et al. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999;135:1000-1.
2. Milkiewicz P, Yim C, Pache I, et al. Diffuse skin reaction in patient with hepatitis B, treated with two different formulations of pegylated interferon. Can J Gastroenterol 2005;19:677-8.
3. Willems M, Munte K, Vrolijk JM, et al. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol 2003;149:390-4.
4. Gurguta C, Kauer C, Bergholz U, et al. Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C. Am J Gastroenterol 2006;101:197-8.
5. Sood A, Midha V, Bansal M, et al. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Indian J Gastroenterol 2006;25:324.
6. Torres HA, Bull L, Arduino RC, et al. Tongue hyperpigmentiation in a Caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol 2007;102:1334-5.
7. Kameyama K, Tanaka S, Ishida Y, et al. Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells. J Clin Invest 1989;83:213-21.